Search

everythinglearnresearchcommunity

for

Search:↓

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Finasteride effectively treats male hair loss, increasing length and thickness.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Men need higher doses and tailored injection techniques for botulinum toxin treatments due to their unique facial features.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Imiquimod cream can rarely cause temporary hair loss.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Hair loss affects women's self-esteem; treatments like minoxidil can help.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The oral contraceptive improved hair and skin quality in women.

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Radiation therapy successfully treated an elderly man's skin cancer and pre-cancerous scalp lesions.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.